Revenue Breakdown
Composition ()
No data
Revenue Streams
Pro-Dex Inc (PDEX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medical devices, accounting for 78.3% of total sales, equivalent to $13.69M. Other significant revenue streams include Repairs and NRE & Prototypes. Understanding this composition is critical for investors evaluating how PDEX navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Pro-Dex Inc maintains a gross margin of 30.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 17.46%, while the net margin is 11.72%. These profitability ratios, combined with a Return on Equity (ROE) of 30.87%, provide a clear picture of how effectively PDEX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, PDEX competes directly with industry leaders such as LNSR and INCR. With a market capitalization of $152.32M, it holds a leading position in the sector. When comparing efficiency, PDEX's gross margin of 30.77% stands against LNSR's 40.56% and INCR's 30.47%. Such benchmarking helps identify whether Pro-Dex Inc is trading at a premium or discount relative to its financial performance.
